PFIZER INC (PFE.DE) Stock Fundamental Analysis

FRA:PFE • US7170811035

22.84 EUR
-0.3 (-1.3%)
Last: Feb 25, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

Overall PFE gets a fundamental rating of 4 out of 10. We evaluated PFE against 52 industry peers in the Pharmaceuticals industry. PFE has a medium profitability rating, but doesn't score so well on its financial health evaluation. PFE is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year PFE was profitable.
  • In the past year PFE had a positive cash flow from operations.
  • Each year in the past 5 years PFE has been profitable.
  • PFE had a positive operating cash flow in 4 of the past 5 years.
PFE.DE Yearly Net Income VS EBIT VS OCF VS FCFPFE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

1.2 Ratios

  • PFE's Return On Assets of 4.71% is in line compared to the rest of the industry. PFE outperforms 42.31% of its industry peers.
  • PFE's Return On Equity of 10.59% is in line compared to the rest of the industry. PFE outperforms 50.00% of its industry peers.
  • PFE's Return On Invested Capital of 7.47% is in line compared to the rest of the industry. PFE outperforms 50.00% of its industry peers.
Industry RankSector Rank
ROA 4.71%
ROE 10.59%
ROIC 7.47%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PFE.DE Yearly ROA, ROE, ROICPFE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • Looking at the Profit Margin, with a value of 15.65%, PFE is in the better half of the industry, outperforming 63.46% of the companies in the same industry.
  • In the last couple of years the Profit Margin of PFE has declined.
  • Looking at the Operating Margin, with a value of 29.12%, PFE is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • PFE's Operating Margin has improved in the last couple of years.
  • With a decent Gross Margin value of 74.95%, PFE is doing good in the industry, outperforming 73.08% of the companies in the same industry.
  • In the last couple of years the Gross Margin of PFE has remained more or less at the same level.
Industry RankSector Rank
OM 29.12%
PM (TTM) 15.65%
GM 74.95%
OM growth 3Y-7.61%
OM growth 5Y5.45%
PM growth 3Y-26.29%
PM growth 5Y-10.8%
GM growth 3Y4.57%
GM growth 5Y-1.03%
PFE.DE Yearly Profit, Operating, Gross MarginsPFE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PFE is destroying value.
  • There is no outstanding debt for PFE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PFE.DE Yearly Shares OutstandingPFE.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
PFE.DE Yearly Total Debt VS Total AssetsPFE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

2.2 Solvency

  • An Altman-Z score of 2.26 indicates that PFE is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.26, PFE perfoms like the industry average, outperforming 42.31% of the companies in the same industry.
  • PFE has a debt to FCF ratio of 5.95. This is a neutral value as PFE would need 5.95 years to pay back of all of its debts.
  • PFE has a Debt to FCF ratio (5.95) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.62 indicates that PFE is somewhat dependend on debt financing.
  • PFE has a Debt to Equity ratio (0.62) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 5.95
Altman-Z 2.26
ROIC/WACC0.88
WACC8.47%
PFE.DE Yearly LT Debt VS Equity VS FCFPFE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.3 Liquidity

  • PFE has a Current Ratio of 1.28. This is a normal value and indicates that PFE is financially healthy and should not expect problems in meeting its short term obligations.
  • PFE has a Current ratio of 1.28. This is comparable to the rest of the industry: PFE outperforms 42.31% of its industry peers.
  • A Quick Ratio of 0.97 indicates that PFE may have some problems paying its short term obligations.
  • The Quick ratio of PFE (0.97) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 0.97
PFE.DE Yearly Current Assets VS Current LiabilitesPFE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 3.86% over the past year.
  • PFE shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.50% yearly.
  • PFE shows a decrease in Revenue. In the last year, the revenue decreased by -1.64%.
  • PFE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.48% yearly.
EPS 1Y (TTM)3.86%
EPS 3Y-21.31%
EPS 5Y3.5%
EPS Q2Q%4.76%
Revenue 1Y (TTM)-1.64%
Revenue growth 3Y-14.8%
Revenue growth 5Y8.48%
Sales Q2Q%-1.16%

3.2 Future

  • Based on estimates for the next years, PFE will show a decrease in Earnings Per Share. The EPS will decrease by -7.23% on average per year.
  • Based on estimates for the next years, PFE will show a decrease in Revenue. The Revenue will decrease by -3.36% on average per year.
EPS Next Y-7.02%
EPS Next 2Y-5.55%
EPS Next 3Y-5.48%
EPS Next 5Y-7.23%
Revenue Next Year-1.61%
Revenue Next 2Y-2.7%
Revenue Next 3Y-4.32%
Revenue Next 5Y-3.36%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PFE.DE Yearly Revenue VS EstimatesPFE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B 100B
PFE.DE Yearly EPS VS EstimatesPFE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 8.34, the valuation of PFE can be described as reasonable.
  • Based on the Price/Earnings ratio, PFE is valued cheaper than 92.31% of the companies in the same industry.
  • PFE's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.05.
  • The Price/Forward Earnings ratio is 8.96, which indicates a very decent valuation of PFE.
  • 92.31% of the companies in the same industry are more expensive than PFE, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 28.03. PFE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.34
Fwd PE 8.96
PFE.DE Price Earnings VS Forward Price EarningsPFE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 86.54% of the companies in the same industry are more expensive than PFE, based on the Enterprise Value to EBITDA ratio.
  • 78.85% of the companies in the same industry are more expensive than PFE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.74
EV/EBITDA 7.53
PFE.DE Per share dataPFE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • PFE's earnings are expected to decrease with -5.48% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)2.38
EPS Next 2Y-5.55%
EPS Next 3Y-5.48%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • PFE has a Yearly Dividend Yield of 6.40%, which is a nice return.
  • PFE's Dividend Yield is rather good when compared to the industry average which is at 1.89. PFE pays more dividend than 100.00% of the companies in the same industry.
  • PFE's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 6.4%

5.2 History

  • The dividend of PFE has a limited annual growth rate of 3.30%.
Dividend Growth(5Y)3.3%
Div Incr Years3
Div Non Decr Years3
PFE.DE Yearly Dividends per sharePFE.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • PFE pays out 98.76% of its income as dividend. This is not a sustainable payout ratio.
  • The Dividend Rate of PFE has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP98.76%
EPS Next 2Y-5.55%
EPS Next 3Y-5.48%
PFE.DE Yearly Income VS Free CF VS DividendPFE.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B
PFE.DE Dividend Payout.PFE.DE Dividend Payout, showing the Payout Ratio.PFE.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

PFIZER INC

FRA:PFE (2/25/2026, 7:00:00 PM)

22.84

-0.3 (-1.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-03
Earnings (Next)04-27
Inst Owners67.61%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap129.86B
Revenue(TTM)62.58B
Net Income(TTM)9.83B
Analysts70.91
Price Target24.87 (8.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.4%
Yearly Dividend1.43
Dividend Growth(5Y)3.3%
DP98.76%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)34.46%
Min EPS beat(2)32.91%
Max EPS beat(2)36.01%
EPS beat(4)4
Avg EPS beat(4)34.72%
Min EPS beat(4)32.52%
Max EPS beat(4)37.45%
EPS beat(8)8
Avg EPS beat(8)54.91%
EPS beat(12)12
Avg EPS beat(12)44.86%
EPS beat(16)16
Avg EPS beat(16)38.4%
Revenue beat(2)1
Avg Revenue beat(2)3.22%
Min Revenue beat(2)-0.53%
Max Revenue beat(2)6.96%
Revenue beat(4)2
Avg Revenue beat(4)1.35%
Min Revenue beat(4)-2.36%
Max Revenue beat(4)6.96%
Revenue beat(8)5
Avg Revenue beat(8)3.39%
Revenue beat(12)7
Avg Revenue beat(12)2.76%
Revenue beat(16)10
Avg Revenue beat(16)3.12%
PT rev (1m)-1.85%
PT rev (3m)-2.57%
EPS NQ rev (1m)0.24%
EPS NQ rev (3m)-4.58%
EPS NY rev (1m)-0.53%
EPS NY rev (3m)-5.18%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-2.66%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-2.25%
Valuation
Industry RankSector Rank
PE 8.34
Fwd PE 8.96
P/S 2.44
P/FCF 14.74
P/OCF 11.7
P/B 1.65
P/tB N/A
EV/EBITDA 7.53
EPS(TTM)2.74
EY12%
EPS(NY)2.55
Fwd EY11.16%
FCF(TTM)1.55
FCFY6.78%
OCF(TTM)1.95
OCFY8.55%
SpS9.38
BVpS13.86
TBVpS-4.13
PEG (NY)N/A
PEG (5Y)2.38
Graham Number29.23
Profitability
Industry RankSector Rank
ROA 4.71%
ROE 10.59%
ROCE 10.62%
ROIC 7.47%
ROICexc 8.19%
ROICexgc 34.99%
OM 29.12%
PM (TTM) 15.65%
GM 74.95%
FCFM 16.53%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-7.61%
OM growth 5Y5.45%
PM growth 3Y-26.29%
PM growth 5Y-10.8%
GM growth 3Y4.57%
GM growth 5Y-1.03%
F-Score6
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 5.95
Debt/EBITDA 2.3
Cap/Depr 40.34%
Cap/Sales 4.3%
Interest Coverage 5.8
Cash Conversion 52.35%
Profit Quality 105.58%
Current Ratio 1.28
Quick Ratio 0.97
Altman-Z 2.26
F-Score6
WACC8.47%
ROIC/WACC0.88
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.86%
EPS 3Y-21.31%
EPS 5Y3.5%
EPS Q2Q%4.76%
EPS Next Y-7.02%
EPS Next 2Y-5.55%
EPS Next 3Y-5.48%
EPS Next 5Y-7.23%
Revenue 1Y (TTM)-1.64%
Revenue growth 3Y-14.8%
Revenue growth 5Y8.48%
Sales Q2Q%-1.16%
Revenue Next Year-1.61%
Revenue Next 2Y-2.7%
Revenue Next 3Y-4.32%
Revenue Next 5Y-3.36%
EBIT growth 1Y-5.75%
EBIT growth 3Y-21.28%
EBIT growth 5Y14.4%
EBIT Next Year15.83%
EBIT Next 3Y2.65%
EBIT Next 5Y0.15%
FCF growth 1Y26.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.12%
OCF growth 3YN/A
OCF growth 5YN/A

PFIZER INC / PFE.DE FAQ

What is the ChartMill fundamental rating of PFIZER INC (PFE.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to PFE.DE.


Can you provide the valuation status for PFIZER INC?

ChartMill assigns a valuation rating of 6 / 10 to PFIZER INC (PFE.DE). This can be considered as Fairly Valued.


What is the profitability of PFE stock?

PFIZER INC (PFE.DE) has a profitability rating of 5 / 10.


What are the PE and PB ratios of PFIZER INC (PFE.DE) stock?

The Price/Earnings (PE) ratio for PFIZER INC (PFE.DE) is 8.34 and the Price/Book (PB) ratio is 1.65.


How financially healthy is PFIZER INC?

The financial health rating of PFIZER INC (PFE.DE) is 3 / 10.